Amanote Research
Register
Sign In
Improving the Antigenicity of sTn Antigen by Modification of Its Sialic Acid Residue for Development of Glycoconjugate Cancer Vaccines
doi 10.1021/bc060103s.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Improving the Antigenicity of sTn Antigen by Modification of Its Sialic Acid Residue for Development of Glycoconjugate Cancer Vaccines
Bioconjugate Chemistry
Organic Chemistry
Biotechnology
Pharmacology
Pharmaceutical Science
Bioengineering
Biomedical Engineering
Antimicrobial Glycoconjugate Vaccines: An Overview of Classic and Modern Approaches for Protein Modification
Chemical Society Reviews
Chemistry
Assessment of Sialic Acid Diversity in Cancer- And Non-Cancer Related CA125 Antigen Using Sialic Acid-Binding Ig-Like Lectins (Siglecs)
Disease Markers
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Genetics
Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines Against Invasive Nontyphoidal Salmonella Disease
PLoS ONE
Multidisciplinary
Understanding the Biology of Antigen Cross-Presentation for the Design of Vaccines Against Cancer
Frontiers in Immunology
Allergy
Immunology
Antigenicity of Irradiated Pasteurella Tularensis Vaccines in Mice
Antigenicity of Methylated Deoxyribonucleic Acid
Tohoku Journal of Experimental Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Evaluation of Ion Mobility for the Separation of Glycoconjugate Isomers Due to Different Types of Sialic Acid Linkage, at the Intact Glycoprotein, Glycopeptide and Glycan Level
Journal of Proteomics
Biochemistry
Biophysics
Development of Mutome-Specific Personalized Vaccines for Pancreatic Cancer
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
